NO20044188L - Controlled release dosage forms - Google Patents
Controlled release dosage formsInfo
- Publication number
- NO20044188L NO20044188L NO20044188A NO20044188A NO20044188L NO 20044188 L NO20044188 L NO 20044188L NO 20044188 A NO20044188 A NO 20044188A NO 20044188 A NO20044188 A NO 20044188A NO 20044188 L NO20044188 L NO 20044188L
- Authority
- NO
- Norway
- Prior art keywords
- dosage forms
- controlled release
- release dosage
- controlled
- forms
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B30—PRESSES
- B30B—PRESSES IN GENERAL
- B30B11/00—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses
- B30B11/34—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses for coating articles, e.g. tablets
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36182102P | 2002-03-04 | 2002-03-04 | |
US29161902A | 2002-11-12 | 2002-11-12 | |
PCT/US2003/006591 WO2003075893A1 (en) | 2002-03-04 | 2003-03-03 | Controlled release dosage forms |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20044188L true NO20044188L (en) | 2004-12-03 |
Family
ID=27807664
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20044188A NO20044188L (en) | 2002-03-04 | 2004-10-01 | Controlled release dosage forms |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1492508A4 (en) |
JP (1) | JP2005524670A (en) |
KR (1) | KR20100049695A (en) |
CN (1) | CN1649569B (en) |
AU (2) | AU2003217909C1 (en) |
BR (1) | BR0308305A (en) |
CA (1) | CA2477701A1 (en) |
EA (1) | EA005866B1 (en) |
IL (1) | IL163887A0 (en) |
MX (1) | MXPA04008536A (en) |
NO (1) | NO20044188L (en) |
NZ (1) | NZ535083A (en) |
WO (1) | WO2003075893A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0203296D0 (en) | 2002-02-12 | 2002-03-27 | Glaxo Group Ltd | Novel composition |
EP1524978A2 (en) * | 2002-07-19 | 2005-04-27 | Ranbaxy Laboratories, Ltd. | Taste masked sumatriptan tablets and processes for their preparation |
US8637512B2 (en) | 2002-07-29 | 2014-01-28 | Glaxo Group Limited | Formulations and method of treatment |
EA200500764A1 (en) * | 2002-11-12 | 2005-12-29 | Тева Фармасьютикал Индастриес Лтд. | PHARMACEUTICAL COMPOSITIONS AND MEDICAL FORMS FOR TRANSBUCCAL AND SUBLINGUAL DELIVERY TIZANIDINE AND METHODS OF INTRODUCTION TIZANIDINE SUBLINGUAL OR TRANSBUCKAL |
WO2005046978A1 (en) * | 2003-11-14 | 2005-05-26 | Sanwa Kagaku Kenkyusho Co., Ltd. | Method of manufacturing nucleated molding |
GB0400452D0 (en) * | 2004-01-09 | 2004-02-11 | Norton Healthcare Ltd | A pharmaceutical composition |
GB0403628D0 (en) * | 2004-02-18 | 2004-03-24 | Arrow Group Ltd | Compression-coated tablets and the manufacture thereof |
US7579333B2 (en) * | 2004-02-19 | 2009-08-25 | Teva Pharmaceutical Industries Ltd. | Therapy using a combination of raloxifene and alendronate |
KR100701409B1 (en) | 2004-11-26 | 2007-03-30 | 한국유나이티드제약 주식회사 | Pharmaceutical formulations containing sumatriptan succinate |
BRPI0917444A2 (en) | 2008-08-15 | 2015-12-01 | Depomed Inc | gastric retention pharmaceutical compositions for the treatment and prevention of snc diseases |
CN110368371A (en) * | 2014-04-08 | 2019-10-25 | 越洋医药开发(广州)有限公司 | A kind of novel controlled release piece |
JP6878417B2 (en) * | 2016-02-17 | 2021-05-26 | トリアステック インコーポレイテッド | Dosage forms and their use |
CN110604724A (en) * | 2019-10-22 | 2019-12-24 | 恒诚制药集团淮南有限公司 | Enteric mesalazine sustained-release tablet and preparation method thereof |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB972128A (en) * | 1960-01-21 | 1964-10-07 | Wellcome Found | Pellets for supplying biologically active substances to ruminants and the manufacture of such pellets |
JPS61243016A (en) * | 1985-04-19 | 1986-10-29 | Katsumi Takada | Tablet having columnar part containing active constituent |
GB8514666D0 (en) * | 1985-06-11 | 1985-07-10 | Coopers Animal Health | Agent delivery systems |
JPS6253918A (en) * | 1985-09-02 | 1987-03-09 | Katsumi Takada | Tablet containing embedded columnar part containing active component |
DE4431653C2 (en) * | 1994-09-06 | 2000-01-20 | Lohmann Therapie Syst Lts | Coated tablet for the controlled release of active substances, a process for their preparation and their use |
US5582838A (en) * | 1994-12-22 | 1996-12-10 | Merck & Co., Inc. | Controlled release drug suspension delivery device |
JP3962108B2 (en) * | 1995-04-03 | 2007-08-22 | 中外製薬株式会社 | Sucralfate-containing pharmaceutical composition |
CA2184316A1 (en) * | 1995-09-12 | 1997-03-13 | Wei-Chi Liao | Buccal delivery system for therapeutic agents |
DK0931543T3 (en) * | 1997-12-19 | 2002-06-17 | Merck Patent Gmbh | Multilayer tablets containing probiotic microorganisms such as lactobacilli or bifidobacteria |
PL192423B1 (en) * | 1997-12-22 | 2006-10-31 | Schering Corp | Molecular dispersion type compositions of enhanced bioassimillability |
JP4748839B2 (en) * | 1999-03-25 | 2011-08-17 | 大塚製薬株式会社 | Cilostazol preparation |
US6499984B1 (en) * | 2000-05-22 | 2002-12-31 | Warner-Lambert Company | Continuous production of pharmaceutical granulation |
DE60137082D1 (en) * | 2000-06-28 | 2009-01-29 | Palmetto Pharmaceuticals Llc | COMPOSITIONS OF ARGININE WITH CONTROLLED RELEASE |
CA2470495A1 (en) * | 2001-12-24 | 2003-07-17 | Teva Pharmaceutical Industries Ltd. | Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it |
-
2003
- 2003-03-03 NZ NZ535083A patent/NZ535083A/en not_active IP Right Cessation
- 2003-03-03 BR BR0308305-5A patent/BR0308305A/en not_active IP Right Cessation
- 2003-03-03 JP JP2003574168A patent/JP2005524670A/en active Pending
- 2003-03-03 CA CA002477701A patent/CA2477701A1/en not_active Abandoned
- 2003-03-03 CN CN038101068A patent/CN1649569B/en not_active Expired - Fee Related
- 2003-03-03 KR KR1020107008536A patent/KR20100049695A/en not_active Application Discontinuation
- 2003-03-03 EP EP03713882A patent/EP1492508A4/en not_active Withdrawn
- 2003-03-03 AU AU2003217909A patent/AU2003217909C1/en not_active Ceased
- 2003-03-03 WO PCT/US2003/006591 patent/WO2003075893A1/en active Application Filing
- 2003-03-03 MX MXPA04008536A patent/MXPA04008536A/en active IP Right Grant
- 2003-03-03 EA EA200401097A patent/EA005866B1/en not_active IP Right Cessation
- 2003-03-03 IL IL16388703A patent/IL163887A0/en unknown
-
2004
- 2004-10-01 NO NO20044188A patent/NO20044188L/en not_active Application Discontinuation
-
2009
- 2009-01-30 AU AU2009200353A patent/AU2009200353A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2003217909B2 (en) | 2008-10-30 |
BR0308305A (en) | 2004-12-28 |
EA200401097A1 (en) | 2005-04-28 |
IL163887A0 (en) | 2005-12-18 |
MXPA04008536A (en) | 2005-09-08 |
KR20100049695A (en) | 2010-05-12 |
AU2009200353A1 (en) | 2009-02-19 |
AU2003217909A1 (en) | 2003-09-22 |
CN1649569B (en) | 2010-05-05 |
EA005866B1 (en) | 2005-06-30 |
JP2005524670A (en) | 2005-08-18 |
EP1492508A1 (en) | 2005-01-05 |
EP1492508A4 (en) | 2009-05-06 |
CN1649569A (en) | 2005-08-03 |
AU2003217909C1 (en) | 2009-06-11 |
WO2003075893A1 (en) | 2003-09-18 |
CA2477701A1 (en) | 2003-09-18 |
NZ535083A (en) | 2007-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS7689A (en) | Multiple component dosage forms | |
NO20052914D0 (en) | Therapeutic compounds | |
DK1553929T3 (en) | Controlled release composition. | |
ATE368042T1 (en) | CEPHEMEM COMPOUNDS | |
DE50308694D1 (en) | IRRADIATOR T | |
ATE318817T1 (en) | AZA-ARYLPIPERAZINE | |
IS7831A (en) | vaccine | |
NO20044046L (en) | Substituted hydroxyethylamines | |
IS7381A (en) | compounds | |
DE60326590D1 (en) | TEND LAMOTRIGIN | |
IS7414A (en) | Oxo-azabicyclic compounds | |
ATE349458T1 (en) | ETONOGESTRELESTER | |
NO20050689L (en) | Therapeutic use | |
DE60327447D1 (en) | PLASTER | |
NO20045659L (en) | compounds | |
IS7582A (en) | Rapid release formulation | |
NO20044188L (en) | Controlled release dosage forms | |
ATE496887T1 (en) | SUBSTITUTED 5-AMINOMETHYL-1H-PYRROL-2-CARBONS UREAMIDE | |
DE60328408D1 (en) | VACCINE | |
ATA1572002A (en) | MANAGEMENTSPLEISSKASSETTE | |
NO20051561D0 (en) | Vaccine | |
ATA4142004A (en) | TRÄGERVERBAU | |
DE50307407D1 (en) | retarder | |
ATA19152002A (en) | HUBKUPPLUNG | |
UA8116S (en) | THERAPEUTIC INDIVIDUAL CAMERA |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |